Vitestro

Vitestro

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17M

Overview

Vitestro is a pioneering medical device company based in Utrecht, Netherlands, focused on automating one of the most common yet variable procedures in healthcare: the blood draw. Its flagship product, Aletta®, is an autonomous robotic system that performs venipuncture from vein identification to bandage application, having achieved CE Marking under the European MDR. The company has secured significant funding, demonstrated clinical efficacy with a 95% first-stick success rate, and is moving into initial commercial deployments with hospital partners in Europe and a strategic collaboration in the US. Vitestro addresses critical challenges of staffing shortages, preanalytical errors, and procedural standardization in the global diagnostic workflow.

Medical DevicesDigital Health

Technology Platform

Autonomous Robotic Phlebotomy Device (ARPD) combining 3D ultrasound imaging, AI-driven vein mapping, robotic needle insertion, and automated sample handling to perform complete blood draws.

Funding History

2
Total raised:$17M
Series A$12M
Seed$5M

Opportunities

Vitestro addresses massive, global challenges in healthcare: chronic staffing shortages for phlebotomists and high rates of preanalytical errors in labs.
Automating this high-volume, manual procedure offers a clear path to standardization, cost savings, and improved patient experience, creating a significant market opportunity in hospital and diagnostic laboratory settings.

Risk Factors

Key risks include navigating the complex FDA regulatory process for US market entry, achieving rapid adoption in a cost-sensitive and change-averse healthcare market, and executing the operational scale-up from developer to global commercial entity.
Competition from future entrants is also a potential risk.

Competitive Landscape

Vitestro appears to be a first-mover in fully autonomous, end-to-end robotic phlebotomy. The competitive landscape includes companies offering vein-finding devices (e.g., infrared viewers) and semi-automated blood drawing aids, but not a fully integrated robotic system. Potential future competitors could include large laboratory automation firms or medical robotics companies expanding into adjacent applications.